Fucoxanthin Enhances Cisplatin-Induced Cytotoxicity via NFκB-Mediated Pathway and Downregulates DNA Repair Gene Expression in Human Hepatoma HepG2 Cells

Fucoxanthin Attenuates Rifampin-Induced Cytochrome P450 3A4 (CYP3A4) and Multiple Drug Resistance 1 (MDR1) Gene Expression Through Pregnane X Receptor (PXR)-Mediated Pathways in Human Hepatoma HepG2 and Colon Adenocarcinoma LS174T Cells

(2012) Cheng-Ling Liu et al.   Marine Drugs

Fucoxanthin Enhances HO-1 and NQO1 Expression in Murine Hepatic BNL CL.2 Cells through Activation of the Nrf2/ARE System Partially by Its Pro-oxidant Activity

(2011) Cheng-Ling Liu et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Synergistic Effect of Curcumin and Cisplatin via Down-Regulation of Thymidine Phosphorylase and Excision Repair Cross-Complementary 1 (ERCC1)

(2011) M.-S. Tsai et al.   MOLECULAR PHARMACOLOGY

Protective effects of fucoxanthin against ferric nitrilotriacetate-induced oxidative stress in murine hepatic BNL CL.2 cells

(2011) Cheng-Ling Liu et al.   TOXICOLOGY IN VITRO

Accumulation of thymidine-derived sugars in thymidine phosphorylase overexpressing cells

(2010) I.V. Bijnsdorp et al.   BIOCHEMICAL PHARMACOLOGY

Fucoxanthin-rich seaweed extract suppresses body weight gain and improves lipid metabolism in high-fat-fed C57BL/6J mice

(2010) Seon-Min Jeon et al.   Biotechnology Journal

Epstein–Barr virus latent membrane protein 1 induces the chemotherapeutic target, thymidine phosphorylase, via NF-κB and p38 MAPK pathways

(2010) Chia-Chun Chen et al.   CELLULAR SIGNALLING

Fucoxanthin inhibits the inflammatory response by suppressing the activation of NF-κB and MAPKs in lipopolysaccharide-induced RAW 264.7 macrophages

(2010) Kil-Nam Kim et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Effects of fucoxanthin on proliferation and apoptosis in human gastric adenocarcinoma MGC-803 cells via JAK/STAT signal pathway

(2010) Rui-xue Yu et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Implication of mitogen-activated protein kinase in the induction of G1 cell cycle arrest and gadd45 expression by the carotenoid fucoxanthin in human cancer cells

(2009) Yoshiko Satomi et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Inhibition of proliferation of a hepatoma cell line by fucoxanthin in relation to cell cycle arrest and enhanced gap junctional intercellular communication

(2009) Cheng-Ling Liu et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Novel strategies for reversing platinum resistance

(2009) Mian M.K. Shahzad et al.   DRUG RESISTANCE UPDATES

Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2

(2009) Jen-Chung Ko et al.   LUNG CANCER

Growth inhibition of human hepatic carcinoma HepG2 cells by fucoxanthin is associated with down-regulation of cyclin D

(2008) Swadesh K. Das et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Toxicity and Antioxidant Activity in Vitro and in Vivo of TwoFucus vesiculosusExtracts

(2008) M. C. Zaragozá et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Protective effect of fucoxanthin isolated from Sargassum siliquastrum on UV-B induced cell damage

(2008) Soo-Jin Heo et al.   JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY

Inhibition of CYP3A4 expression by ketoconazole is mediated by the disruption of pregnane X receptor, steroid receptor coactivator-1, and hepatocyte nuclear factor 4α interaction

(2008) Yun-Ping Lim et al.   Pharmacogenetics and Genomics